Junctional adhesion molecule: An expression in human endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 19, Issue 2, 2009, Pages 208-213

  Koshiba, Hisato ^a   Hosokawa, Kenichi ^a   Kubo, Akiko ^b   Tokumitsu, Norimasa ^c   Watanabe, Ai ^a   Honjo, Hideo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c Tokyo Scientific Laboratory   (Japan)

Author keywords

3 dimensional culture; Endometrial carcinoma; Histologic grade; Junctional adhesion molecule A; Prognostic factor

Indexed keywords

JUNCTIONAL ADHESION MOLECULE A; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; JUNCTIONAL ADHESION MOLECULE A , HUMAN; JUNCTIONAL ADHESION MOLECULE-A , HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CELL ADHESION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; ADENOCARCINOMA; BIOSYNTHESIS; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; AGED; CELL ADHESION MOLECULES; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED;

EID: 65649144763     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e31819bc6e9     Document Type: Article

References (38)

1. Liu Y, Nusrat A, Schnell FJ, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci. 2000;113: 2363-2374.
2. Bazzoni G, Martínez-Estrada OM, Orsenigo F, et al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem. 2000;275:20520-20526.
3. Liang TW, DeMarco RA, Mrsny RJ, et al. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol. 2000;279:C1733-C1743.
4. Itoh M, Sasaki H, Furuse M, et al. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol. 2001;154:491-497.
5. Fukuhara A, Irie K, Nakanishi H, et al. Involvement of nectin in the localization of junctional adhesion molecule at tight junctions. Oncogene. 2002;21:7642-7655.
6. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol. 2003;15:525-530.
7. Ebnet K, Suzuki A, Ohno S, et al. Junctional adhesion molecules (JAMs): More molecules with dual functions? J Cell Sci. 2004; 117:19-29.
8. Keiper T, Santoso S, Nawroth PP, et al. The role of junctional adhesion molecules in cell-cell interactions. Histol Histopathol. 2005;20: 197-203.
9. Mandell KJ, Parkos CA. The JAM family proteins. Adv Drug Deliv Rev. 2005;57:857-867.
10. Naik UP, Eckfeld K. Junctional adhesion molecule 1 (JAM-1). J Biol Regul Homeost Agents. 2003;17:341-347.
11. Aurrand-Lions M, Johnson-Léger C, Lamagna C, et al. Junctional adhesion molecules and interendothelial junctions. Cells Tissues Organs. 2002;172:152-160.
12. Sakuragi N, Nishiya M, Ikeda K, et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 1994;53:183-189.
13. Fujimoto J, Ichigo S, Hori M, et al. Expressions of E-cadherin and α-and β-catenin mRNAs in uterine endometrial cancers. Eur J Gynaecol Oncol. 1998;19:78-81.
14. Mell LK, Meyer JJ, Tretiakova M, et al. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Clin Cancer Res. 2004;10:5546-5553.
15. Shih HC, Shiozawa T, Miyamoto T, et al. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Anticancer Res. 2004;24:3843-3850.
16. Scholten AN, Aliredjo R, Creutzberg CL, et al. Combined E-cadherin, α-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma. Int J Gynecol Cancer. 2006;16:1379-1385.
17. Athanassiadou P, Athanassiades P, Grapsa D, et al. The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study. Int J Gynecol Cancer. 2007;17:697-704.
18. Nei H, Saito T, Tobioka H, et al. Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation. Cancer. 1996;78;461-470.
19. Tobioka H, Isomura H, Kokai Y, et al. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol. 2004;35:159-164.
20. Lessey BA, Albelda S, Buck CA, et al. Distribution of integrin cell adhesion molecules in endometrial cancer. Am J Pathol. 1995; 146:717-726.
21. Inoue Y, Abe K, Obata K, et al. Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma. J Obstet Gynaecol Res. 1997;23:139-145.
22. Ayhan A, Tok EC, Bildirici I, et al. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance. Gynecol Oncol. 2001;80:355-358.
23. Hong SC, Song JY, Lee JK, et al. Significance of CD44v6 expression in gynecologic malignancies. J Obstet Gynaecol Res. 2006;32: 379-386.
24. Bamberger AM, Riethdorf L, Nollau P, et al. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol. 1998;152:1401-1406.
25. Miyamoto S, Maruyama A, Okugawa K, et al. Loss of motility-related protein 1 (MRP1/CD9) and integrin α3 expression in endometrial cancers. Cancer. 2001;92:542-548.
26. O'Brien LE, Zegers MM, Mostov KE. Opinion: building epithelial architecture: insights from three-dimensional culture models. Nat Rev Mol Cell Biol. 2002:531-537.
27. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5:675-688.
28. Fujimoto J, Hori M, Ichigo S, et al. Estrogen activates migration potential of endometrial cancer cells through basement membrane. Tumour Biol. 1996;17:48-57.
29. Strunck E, Hopert AC, Vollmer G. Basement membrane regulates gene expression in HEC1B (L) endometrial adenocarcinoma cells. Biochem Biophys Res Commun. 1996;221:346-350.
30. Hopfer H, Rinehart CA Jr, Kaufman DG, et al. Basement membrane induced differentiation of HEC-1B (L) endometrial adenocarcinoma cells affects both morphology and gene expression. Biochem Cell Biol. 1996;74:165-177.
31. Pinelli DM, Drake J, Williams MC, et al. Hormonal modulation of Ishikawa cells during three-dimensional growth in vitro. J Soc Gynecol Investig. 1998;5:217-223.
32. Prifti S, Zourab Y, Koumouridis A, et al. Role of integrins in invasion of endometrial cancer cell lines. Gynecol Oncol. 2002;84:12-20.
33. Park YH, Ryu HS, Choi DS, et al. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int J Gynecol Cancer. 2003;13:53-60.
34. Park DW, Choi DS, Ryu HS, et al. A well-defined in vitro three-dimensional culture of human endometrium and its applicability to endometrial cancer invasion. Cancer Lett. 2003;195: 185-192.
35. Tanaka R, Saito T, Ashihara K, et al. Three-dimensional coculture of endometrial cancer cells and fibroblasts in human placenta derived collagen sponges and expression matrix metalloproteinases in these cells. Gynecol Oncol. 2003;90:297-304.
36. Koistinen H, Seppälä M, Knuutila S, et al. Extracellular matrix-induced changes in expression of cell cycle-related proteins and proteasome components in endometrial adenocarcinoma cells. Gynecol Oncol. 2006;102:546-551.
37. McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985; 109:716-721.
38. Oyama T, Kanai Y, Ochiai A, et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res. 1994;54:6282-6287.